Cookies help us to understand how you use our website so that we can provide you with the best experience when you are on our site. To find out more, read our privacy policy and cookie policy.
Manage Cookies
A cookie is information stored on your computer by a website you visit. Cookies often store your settings for a website, such as your preferred language or location. This allows the site to present you with information customized to fit your needs. As per the GDPR law, companies need to get your explicit approval to collect your data. Some of these cookies are ‘strictly necessary’ to provide the basic functions of the website and can not be turned off, while others if present, have the option of being turned off. Learn more about our Privacy and Cookie policies. These can be managed also from our cookie policy page.
Strictly necessary cookies(always on):
Necessary for enabling core functionality. The website cannot function properly without these cookies. This cannot be turned off. e.g. Sign in, Language
Analytics cookies:
Analytical cookies help us to analyse user behaviour, mainly to see if the users are able to find and act on things that they are looking for. They allow us to recognise and count the number of visitors and to see how visitors move around our website when they are using it. Tools used: Google Analytics
Social media cookies:
We use social media cookies from Facebook, Twitter and Google to run Widgets, Embed Videos, Posts, Comments and to fetch profile information.
Event: Working to diagnose and track cancer better - Circulating Biomarker Network
Share Event: Working to diagnose and track cancer better - Circulating Biomarker Network on FacebookShare Event: Working to diagnose and track cancer better - Circulating Biomarker Network on TwitterShare Event: Working to diagnose and track cancer better - Circulating Biomarker Network on LinkedinEmail Event: Working to diagnose and track cancer better - Circulating Biomarker Network link
The Circulating Biomarker Network is developing genomic tests to improve cancer diagnostic services in England. We aim to make it easier to use blood tests to check for cancer. In this way, doctors won’t need to do as many invasive biopsies and more patients will avoid the discomfort of biopsies and get the most appropriate treatment faster. The Network is part of the NHS England Genomic Networks of Excellence (NHS England » NHS Genomic Networks of Excellence(External link)).
Guests from all backgrounds who are interested in the topic or who have been affected by breast cancer, cancer in children, germ-cell tumours, lymphoma, or any other type of cancer are invited to join us in central London (or online) on 19th July from 2pm to 5pm. We want to ensure that the developed tests meet the needs of patients, the public and health professionals delivering the service, and that there is widespread knowledge of these services and how to access them and to ensure equity of access to high quality care across the country.
This meeting will be a good opportunity for the Network to listen to members of the public, discuss ways for improvements, and answer any questions they might have.
The Circulating Biomarker Network is developing genomic tests to improve cancer diagnostic services in England. We aim to make it easier to use blood tests to check for cancer. In this way, doctors won’t need to do as many invasive biopsies and more patients will avoid the discomfort of biopsies and get the most appropriate treatment faster. The Network is part of the NHS England Genomic Networks of Excellence (NHS England » NHS Genomic Networks of Excellence(External link)).
Guests from all backgrounds who are interested in the topic or who have been affected by breast cancer, cancer in children, germ-cell tumours, lymphoma, or any other type of cancer are invited to join us in central London (or online) on 19th July from 2pm to 5pm. We want to ensure that the developed tests meet the needs of patients, the public and health professionals delivering the service, and that there is widespread knowledge of these services and how to access them and to ensure equity of access to high quality care across the country.
This meeting will be a good opportunity for the Network to listen to members of the public, discuss ways for improvements, and answer any questions they might have.
